Policy Lab
Policy Lab is a San Diego-based clinical trial search and education platform that connects patients, caregivers, and families with over 500,000 actively recruiting clinical trials across all 50 US states via free self-serve search, educational content, and affiliate-supported provider comparisons.
- Company typePrivate
- Founded2017
- HeadquartersSan Diego, United States
- Headcount1–10
- GTM typeB2C
- OfferingDigital Commerce or Content
What Policy Lab does
Policy Lab is a San Diego-based private company founded in 2017 that operates a consumer-facing clinical trial discovery and education platform at policylab.us. The platform aggregates over 500,000 actively recruiting clinical trials searchable by condition, treatment area, state, age, gender, and study type, paired with educational content on conditions, treatments, and clinical trial participation written for patients, caregivers, and families. Its product surface extends beyond search into condition and treatment directories, state-by-state directories covering all 50 US states, and specialized educational guides targeting seniors, minority populations, parents, and healthy volunteers seeking compensation.
The company monetizes primarily through affiliate/referral partnerships, notably with OnlineSemaglutide for GLP-1 medications, and a paid "Post A Trial" service that allows sponsors and research organizations to list trials on the platform. Its technology relies on third-party clinical trial data feeds from partners including Citeline/Norstella and Antidote for matching, supplemented by an SEO-driven content marketing strategy that includes dedicated hubs for semaglutide, tirzepatide, hormone replacement therapy, and testosterone replacement therapy, with provider comparison pages. Distribution is exclusively digital and self-serve, targeting US consumers with no mobile app or API offering; the company operates with a very small team of 1-10 employees, no disclosed external funding, and a single named co-founder, Tyler Cooper.
The business model is essentially a content-and-affiliate play rather than a software-as-a-service platform, with a nascent Healthcare Analytics Unit offering administrative-data research support to investigators as a secondary B2B surface. There are no disclosed revenue figures, no funding rounds, no patent portfolio, and no regulatory or certification disclosures in the available data, and the company competes in a clinical trial discovery market that includes both specialized players (e.g., Antidote, ClinicalTrials.gov) and large incumbents embedding trial matching into broader consumer health and EHR experiences.
Policy Lab firmographics
Firmographics- Name
- Policy Lab
- Website
- https://policylab.us
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Policy Lab is a San Diego-based clinical trial search and education platform that connects patients, caregivers, and families with over 500,000 actively recruiting clinical trials across all 50 US states via free self-serve search, educational content, and affiliate-supported provider comparisons.
- Ownership category
- akta.pro rank
Policy Lab industry classification
Industry- Product category
- Clinical Trial Search Platform
- NAICS
- Scientific Research and Development Services (5417)
- SIC
- Services-Health Services (8000)
- akta.pro primary industry
- Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF) (HLAGAJAM)
Keywords
Where Policy Lab is headquartered
LocationHeadquarters
- HQ city
- San Diego
- HQ country
- United States
- HQ region
- North America
Markets served
Policy Lab business model
Business model- GTM type
- B2C
- Offering type
- Digital Commerce or Content
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Partner Sponsorships and Referrals: Policy Lab partners with clinical trial sponsors, healthcare companies, and pharmaceutical companies to feature their trials and treatments on the platform. The site includes sponsored content and affiliate partnerships with providers like OnlineSemaglutide for GLP-1 medications.
- Post-a-Trial Service: Sponsors and research organizations can pay to post their clinical trials on the platform to reach participants.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels3 records
Policy Lab product offering
Product offeringCore offering
Policy Lab operates a free clinical trial search and education platform that connects patients, caregivers, and families with over 500,000 actively recruiting clinical trials across the United States. Users can search trials by condition, state, age, gender, and study type, and access educational resources on conditions, treatments, and clinical research participation. The company also offers a free Post-A-Trial service for sponsors and research organizations to publish their trials on the platform, generating its primary revenue.
Product overview
Policy Lab is a clinical trial education and search platform that connects patients, caregivers, and families with clinical research opportunities. The core product is a clinical trial search platform offering access to over 500,000 actively recruiting trials searchable by condition, treatment area, state, age, gender, and study type. The platform provides condition and treatment directories, a free trial posting service for sponsors, and educational resources including guides on clinical trial diversity, senior participation, compensation, and pediatric trials. Additional offerings include hormone replacement therapy resources covering menopausal HRT, testosterone replacement therapy, and gender-affirming care; semaglutide and tirzepatide medication hubs with provider comparisons; and a Healthcare Analytics Unit supporting investigators with administrative data research. The platform covers clinical trials across all 50 US states.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 500,000+ clinical trials available on the platform
- +2 more outcomes
Companies that use Policy Lab
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles4 records
Policy Lab technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Policy Lab partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered major, core and minor.
- Citeline/NorstellamajorCiteline/Norstella provides clinical trial data and listings integrated into the Policy Lab platform, enabling access to their comprehensive clinical trial database.
- University of MichiganmajorUniversity of Michigan is listed as a partner organization, contributing to the platform's clinical trial offerings and research mission.
- AntidotecoreAntidote provides clinical trial matching technology integrated into the Policy Lab platform to help patients find relevant trials.
- Northwestern UniversitymajorNorthwestern University collaborates with Policy Lab as a research and academic partner.
- OnlineSemaglutideminorPolicy Lab partners with OnlineSemaglutide to offer compounded GLP-1 medications at reduced costs to users, earning affiliate referral revenue.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
Policy Lab competitors and assessment
Company assessmentDirect peers
- Antidote: Antidote is a patient-facing clinical trial search and matching platform that operates in the same category as Policy Lab, helping patients find trials by condition and location. Policy Lab already integrates Antidote's matching technology, making them both partner and direct competitor.
- Deep 6 AI: Deep 6 AI uses AI and EHR data to match patients to clinical trials, competing directly with Policy Lab in patient recruitment and trial discovery for sponsors and patients. It represents a more software-intensive, enterprise-focused evolution of the same use case.
- Massive Bio: Massive Bio is an AI-driven clinical trial matching platform focused on oncology and rare diseases, providing patient recruitment services to sponsors. It is a direct competitor in the patient-facing clinical trial discovery space.
- CenterWatch: CenterWatch is a long-standing clinical trial listing and patient information publisher. It competes with Policy Lab as a content-driven trial discovery destination for patients and caregivers.
Broad incumbents
- ClinicalTrials.gov: ClinicalTrials.gov is the US government's free registry of clinical trials and the canonical source of trial data that Policy Lab aggregates. It competes head-to-head as a free patient search destination and effectively sets the price floor at zero for trial discovery.
- Citeline / Norstella: Citeline (Norstella) provides clinical trial data, intelligence, and analytics to the pharma industry and also owns competitor Antidote. It supplies Policy Lab's core trial database, making it both a critical partner and a potential competitive threat as an integrated incumbent.
- BBK Worldwide: BBK Worldwide is an established patient recruitment and engagement agency serving trial sponsors. It competes for the same sponsor recruitment budgets that Policy Lab targets through its Post A Trial service, though BBK operates primarily as a full-service agency.
Emerging players
- Mendel: Mendel applies NLP to clinical trial matching and patient cohort identification, serving both sponsors and providers. It overlaps with Policy Lab in patient-facing trial discovery while adding enterprise analytics layers.
- SubjectWell: SubjectWell connects patients with clinical trials via a consumer-facing marketplace model, monetizing on the sponsor side. It overlaps with Policy Lab in trial-discovery UX and SEO-driven patient acquisition.
- Power Life Sciences: Power Life Sciences provides AI-enabled clinical trial site identification and patient recruitment services. It targets similar sponsors and overlaps in patient discovery and matching capabilities.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights5 records
Customer concentration
Policy Lab social profiles
Digital presencePolicy Lab financial estimates
Financial estimateRevenue estimate
Valuation estimate
Policy Lab leadership team
Management profileNumber of profiles
Profiles1 record
Policy Lab funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Policy Lab M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Policy Lab
What does Policy Lab do?
Policy Lab operates a free clinical trial search and education platform that connects patients, caregivers, and families with over 500,000 actively recruiting clinical trials across the United States. Users can search trials by condition, state, age, gender, and study type, and access educational resources on conditions, treatments, and clinical research participation. The company also offers a free Post-A-Trial service for sponsors and research organizations to publish their trials on the platform, generating its primary revenue.
Is Policy Lab a public or private company?
Policy Lab is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Policy Lab founded?
Policy Lab was founded in 2017. It employs 1 to 10 people.
Where is Policy Lab based?
Policy Lab is headquartered in San Diego, United States, in the North America region.
How does Policy Lab make money?
Two revenue lines are on record. Partner Sponsorships and Referrals are the primary driver. The others are post-a-Trial Service.
Who are Policy Lab's main competitors?
Direct peers on record are Antidote, Deep 6 AI, Massive Bio and CenterWatch. Broad incumbents are ClinicalTrials.gov, Citeline / Norstella and BBK Worldwide. Emerging players are Mendel, SubjectWell and Power Life Sciences.
Does Policy Lab have an API?
No public API is recorded for Policy Lab.
What industry is Policy Lab in?
Policy Lab's product category is Clinical Trial Search Platform. Its primary akta.pro industry code is HLAGAJAM, Clinical Trial Informatics (EDC/CTMS/eCOA/eTMF). Its NAICS code is 5417 and its SIC code is 8000.